ICON plc Announces Timing Update for Q4 and Full-Year 2025 Earnings and Accounting Investigation
ICON plc announces revised timeline for Q4 and full-year 2025 earnings as investigation into accounting practices continues. ICON plc, today announced that it intends to release its fourth quarter and full…
GSK’s Arexvy RSV Vaccine Gains U.S. Approval for At-Risk Adults Aged 18–49
FDA Expands Approval of GSK’s RSV Vaccine Arexvy to Include At-Risk Adults Aged 18–49 GSK plc today announced that the US Food and Drug Administration (FDA) has expanded the approved…
Novartis’ Cosentyx® Gains FDA Approval for Patients 12 and Older With Moderate-to-Severe Hidradenitis Suppurativa
Novartis’s Cosentyx gains U.S. Food and Drug Administration approval for patients aged 12+ with moderate-to-severe Hidradenitis Suppurativa. Novartis announced today that Cosentyx® (secukinumab) received US Food and Drug Administration (FDA) approval…
Johnson & Johnson Reports Encouraging First-in-Human Results for Erda-iDRS (TAR-210) in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
Johnson & Johnson Reports Encouraging First-in-Human Data for Erda-iDRS (formerly TAR-210) in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Johnson & Johnson today announced results from an open-label, multicenter Phase 1 study evaluating…
WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Bioprocessing, Manufacturing, and Digital Innovation Leadership
WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Advancements in Bioprocessing, Manufacturing Quality, and Digital Innovation WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing…
Celltrion Poised to Gain from Global Biosimilar Regulatory Harmonization, Boosting Scale from Development to Commercialization
Celltrion Poised to Gain from Global Biosimilar Regulatory Harmonization, Enhancing Economies of Scale from Development to Manufacturing and Direct Commercialization Celltrion announced today that it will immediately incorporate newly announced…
Johnson & Johnson Secures FDA Approval for TECNIS PureSee Intraocular Lens to Improve Cataract Vision in the U.S.
Johnson & Johnson Secures U.S. Food and Drug Administration Approval for TECNIS PureSee Intraocular Lens, Expanding Vision Care Options for U.S. Cataract Patients Johnson & Johnson announced U.S. Food and Drug…
Eli Lilly and Company Issues Safety Warning on Tirzepatide Compounded with Vitamin B12
Eli Lilly and Company Issues Open Letter Warning About Potential Patient Safety Risks of Tirzepatide Compounded with Vitamin B12 Lilly is issuing a public warning about potential safety risks associated…
Curatis, Neupharma Partner to Develop and Commercialize Corticorelin for Brain Edema in Japan
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a…
GoodRx Partners with Viatris to Provide Up to 85% Savings on Brand Medications
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications GoodRx the leading platform for prescription savings in the U.S., announced a new collaboration with Viatris,…
Planet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry
Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…
Tempus AI Study Reveals Impact of Advanced Genomic Profiling in Detecting Actionable Findings
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings Tempus AI, Inc. a technology company leading the adoption of AI to advance precision…